The transitional phase of multiple sclerosis: The concept of PANGAEA 2.0 evolution study

Mult Scler Relat Disord. 2020 Nov:46:102523. doi: 10.1016/j.msard.2020.102523. Epub 2020 Sep 19.

Authors

Hernan Inojosa¹, Benedict Rauser², Benjamin Ettle², Tjalf Ziemssen³

Affiliations

¹ Center of Clinical Neuroscience, Department of Neurology, Carl Gustav Carus University Hospital Dresden, Fetscherstr. 74, 01307 Dresden, Germany.
² Novartis Pharma GmbH, Nueremberg, Germany.
³ Center of Clinical Neuroscience, Department of Neurology, Carl Gustav Carus University Hospital Dresden, Fetscherstr. 74, 01307 Dresden, Germany.. Electronic address: Tjalf.Ziemssen@uniklinikum-dresden.de.

PMID: 32977073
DOI: 10.1016/j.msard.2020.102523

No abstract available

Publication types

Letter

MeSH terms

Fingolimod Hydrochloride
Humans
Multiple Sclerosis*

Substances

Fingolimod Hydrochloride